The story · written by gpt-6,
Aruba gave cannabidiol, or CBD, a medicinal status in December 2019 and excluded CBD preparations containing no more than 0.2% THC from a narcotics designation.[1][2] The rules responded to growing use of cannabis preparations for health reasons, with the minister calling for safeguards to protect consumers.[1][2]
People were already using cannabis preparations
The regulations’ explanations described increasing use of preparations that were not standardised.[1][2] Health minister Dangui Oduber chose to address that use through medicine and narcotics rules, with separate decisions about CBD’s classification and the products containing it.[1][2]
The regulations were signed on 20 December, published on 23 December and took effect the following day.[1][2][3] For people seeking CBD products, the package therefore changed the rules from 24 December 2019.[1][2][3]
A THC ceiling shaped the exception
One rule designated CBD and its preparations as medicines, including preparations combined with THC.[1] It also allowed CBD preparations with no more than 0.2% THC to be stocked and supplied by people beyond the categories normally named in the medicines law.[1]
A second rule addressed cannabis preparations, extracts and tinctures under the narcotics ordinance.[2] It made an exception for CBD and its preparations with THC content at or below 0.2%.[2] The percentage was therefore a condition attached to the CBD exception.[2]
The supplement exemption lasted only weeks
A companion regulation dealt with products used for purposes other than medicine.[3] It excluded specified external-use products, herbs, supplements, foods and drinks from medicinal classification when they contained no more than 0.2% THC.[3]
That arrangement was short-lived.[4] In January, Oduber withdrew the companion rule because it did not fully match the intended CBD policy.[4] The withdrawal took effect on 17 January 2020, leaving the separate medicine designation and narcotics exception outside the repeal’s scope.[1][2][4]
CBD imports became a regulated medicinal route
Aruba later created a medicinal-cannabis agency to oversee a proposed cultivation, manufacturing and trading system, with duties covering quality, permits and stocks.[5]
The health inspectorate’s current guidance treats CBD products with no more than 0.2% THC as medicines.[6] Businesses seeking to import, store and distribute them need permission from the health minister, following an inspectorate assessment of legal requirements, quality and safety.[6]
That permission process is the practical commercial route described today for low-THC CBD in Aruba.[6]
Listed for context. No score change is recorded for Aruba here.
References
- Aruba — Designation of cannabidiol as a medicine, AB 2019 no. 82Articles 1–3; signed 20 December, published 23 December, effective 24 December 2019archived
- Aruba — Cannabidiol narcotics regulation, AB 2019 no. 83Articles 1–2; CBD exception up to 0.2% THC; effective 24 December 2019archived
- Aruba — Cannabidiol non-medicinal product exceptions, AB 2019 no. 84Articles 1–3; effective 24 December 2019; later repealedarchived
- Aruba — Withdrawal of the cannabidiol product exceptions, AB 2020 no. 7Articles I–II; published 16 January, effective 17 January 2020archived
- Aruba — Decree creating the Bureau Medicinale Cannabis Aruba, 9 June 2020 no. 2Landscourant 3 July 2020, pp. 34–36; retroactive effect from 1 June 2020archived
- Inspectie Volksgezondheid Aruba — Importing CBD productsCurrent official guidance on medicines with no more than 0.2% THC; read 23 October 2026archived
Checked. The date and the event were compared with a source that was read.